BRIEF published on 11/07/2024 at 18:35, 1 year 7 months ago Subsidiary of MammoRisk by Predilife for €202 million MammoRisk Breast Cancer International Development Subsidiary Valorization
PRESS RELEASE published on 11/07/2024 at 18:30, 1 year 7 months ago Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 M EUR Predilife annonce la réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 M€ pour favoriser son développement international. Création de valeur et partenariats en vue Développement International Valorisation PREDILIFE MammoRisk Apport Partiel D'actif
BRIEF published on 10/30/2024 at 19:05, 1 year 7 months ago Predilife publie son rapport financier semestriel 2024 Euronext Growth Rapport Financier Intelligence Artificielle PREDILIFE Prédiction Médicale
BRIEF published on 10/30/2024 at 19:05, 1 year 7 months ago Predilife publishes its 2024 half-yearly financial report Artificial Intelligence Financial Report Euronext Growth PREDILIFE Medical Prediction
PRESS RELEASE published on 10/30/2024 at 19:00, 1 year 7 months ago Predilife met à disposition son rapport financier semestriel 2024 Predilife met à disposition son rapport financier semestriel 2024, spécialiste des solutions de prédiction de pathologies pour une médecine personnalisée Rapport Financier Médecine Personnalisée PREDILIFE Pathologies Prédiction
BRIEF published on 10/28/2024 at 08:35, 1 year 7 months ago Résultats Semestriels et Perspectives de PREDILIFE pour 2024 Résultats Financiers Partenariats Stratégiques Croissance 2024 PREDILIFE MammoRisk®
BRIEF published on 10/28/2024 at 08:35, 1 year 7 months ago PREDILIFE Half-Yearly Results and Outlook for 2024 Financial Results Strategic Partnerships Growth 2024 PREDILIFE MammoRisk®
PRESS RELEASE published on 10/28/2024 at 08:30, 1 year 7 months ago Résultats semestriels 2024 - Perspectives de croissance 2024 Annonce des résultats semestriels 2024 et perspectives de croissance pour PREDILIFE, spécialiste des solutions de prédiction de risques de pathologies. Des partenariats stratégiques et une croissance attendue Croissance Résultats Semestriels Partenariats Stratégiques PREDILIFE Bilans Prédictifs
BRIEF published on 10/21/2024 at 18:35, 1 year 8 months ago Le Groupe Rocher s'engage pour la santé des femmes avec PREDILIFE PREDILIFE Cancer Du Sein Octobre Rose Groupe Rocher Prévention Santé
BRIEF published on 10/21/2024 at 18:35, 1 year 8 months ago The Rocher Group is committed to women's health with PREDILIFE PREDILIFE Breast Cancer Pink October Rocher Group Health Prevention
Published on 06/20/2026 at 01:00, 2 days 4 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 5 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 4 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 04:05, 1 hour 18 minutes ago Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises
Published on 06/20/2026 at 21:25, 1 day 7 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 23 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 9 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 9 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:33, 2 days 9 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 9 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 10 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 10 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
